Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000987292 | SCV001136550 | benign | Hypogonadotropic hypogonadism 4 with or without anosmia | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003994180 | SCV004813781 | benign | not specified | 2024-02-29 | criteria provided, single submitter | clinical testing | Variant summary: PROK2 c.-4C>A is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.00013 in 1237522 control chromosomes, predominantly at a frequency of 0.0024 within the African or African-American subpopulation in the gnomAD database. c.-4C>A has been reported in the literature in at-least one individual affected with Kallmann syndrome without strong evidence for causality (example: Dode_2006). This report does not provide unequivocal conclusions about association of the variant with Hypogonadotropic Hypogonadism 4 With Or Without Anosmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 17054399). ClinVar contains an entry for this variant (Variation ID: 801987). Based on the evidence outlined above, the variant was classified as benign. |
Gene |
RCV004702554 | SCV005201986 | uncertain significance | not provided | 2024-03-04 | criteria provided, single submitter | clinical testing | Identified in the heterozygous state in an individual with Kallmann syndrome in published literature (PMID: 17054399); This variant is associated with the following publications: (PMID: 17054399) |
Prevention |
RCV003936239 | SCV004756675 | likely benign | PROK2-related disorder | 2021-08-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |